Jardiance

Jardiance Indications/Uses

empagliflozin

Manufacturer:

Boehringer Ingelheim

Distributor:

Metro Drug
Full Prescribing Info
Indications/Uses
Glycaemic control: Empagliflozin (Jardiance) is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults as: Monotherapy: When diet and exercise alone do not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate due to intolerance.
Add-on combination therapy: In combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control (see Pharmacology: Pharmacodynamics: Clinical Trials under Actions).
Prevention of cardiovascular death: Empagliflozin (Jardiance) is indicated in patients with type 2 diabetes mellitus and established cardiovascular disease to reduce the risk of cardiovascular death (see Pharmacology: Pharmacodynamics: Clinical Trials under Actions). To prevent cardiovascular deaths, Empagliflozin (Jardiance) should be used in conjunction with other measures to reduce cardiovascular risk in line with the current standard of care.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in